| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6805045
[patent_doc_number] => 20030232439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Antisense modulation of VEGF-B expression'
[patent_app_type] => new
[patent_app_number] => 10/174128
[patent_app_country] => US
[patent_app_date] => 2002-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31320
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232439.pdf
[firstpage_image] =>[orig_patent_app_number] => 10174128
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/174128 | Antisense modulation of VEGF-B expression | Jun 16, 2002 | Abandoned |
Array
(
[id] => 6805048
[patent_doc_number] => 20030232442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Antisense modulation of PAZ/PIWI domain-containing protein expression'
[patent_app_type] => new
[patent_app_number] => 10/175492
[patent_app_country] => US
[patent_app_date] => 2002-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31883
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232442.pdf
[firstpage_image] =>[orig_patent_app_number] => 10175492
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/175492 | Antisense modulation of PAZ/PIWI domain-containing protein expression | Jun 16, 2002 | Abandoned |
Array
(
[id] => 6825288
[patent_doc_number] => 20030235910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-25
[patent_title] => 'Antisense modulation of G protein-coupled receptor 49 expression'
[patent_app_type] => new
[patent_app_number] => 10/174456
[patent_app_country] => US
[patent_app_date] => 2002-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31842
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20030235910.pdf
[firstpage_image] =>[orig_patent_app_number] => 10174456
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/174456 | Antisense modulation of G protein-coupled receptor 49 expression | Jun 16, 2002 | Abandoned |
| 10/049743 | Antisense modulation of p13 kinase p110 delta expression | Jun 9, 2002 | Abandoned |
Array
(
[id] => 6678549
[patent_doc_number] => 20030228690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Antisense modulation of IL-1 receptor-associated kinase-1 expression'
[patent_app_type] => new
[patent_app_number] => 10/167034
[patent_app_country] => US
[patent_app_date] => 2002-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31718
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20030228690.pdf
[firstpage_image] =>[orig_patent_app_number] => 10167034
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/167034 | Antisense modulation of IL-1 receptor-associated kinase-1 expression | Jun 9, 2002 | Abandoned |
Array
(
[id] => 6701631
[patent_doc_number] => 20030224511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Antisense modulation of cathepsin Z expression'
[patent_app_type] => new
[patent_app_number] => 10/159266
[patent_app_country] => US
[patent_app_date] => 2002-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30265
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20030224511.pdf
[firstpage_image] =>[orig_patent_app_number] => 10159266
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/159266 | Antisense modulation of cathepsin Z expression | May 30, 2002 | Abandoned |
Array
(
[id] => 6702131
[patent_doc_number] => 20030225011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Phospholipase A2 expression and activity and use thereof for diagnosis, prognostication, prevention and treatment of neural inflammatory and demyelinating disease'
[patent_app_type] => new
[patent_app_number] => 10/157898
[patent_app_country] => US
[patent_app_date] => 2002-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 19486
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20030225011.pdf
[firstpage_image] =>[orig_patent_app_number] => 10157898
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/157898 | Phospholipase A2 expression and activity and use thereof for diagnosis, prognostication, prevention and treatment of neural inflammatory and demyelinating disease | May 30, 2002 | Abandoned |
Array
(
[id] => 6702132
[patent_doc_number] => 20030225012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Antisense modulation of transcription factor DP-1 expression'
[patent_app_type] => new
[patent_app_number] => 10/160554
[patent_app_country] => US
[patent_app_date] => 2002-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29376
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20030225012.pdf
[firstpage_image] =>[orig_patent_app_number] => 10160554
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/160554 | Antisense modulation of transcription factor DP-1 expression | May 30, 2002 | Abandoned |
Array
(
[id] => 6702135
[patent_doc_number] => 20030225015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Antisense modulation of Rb2/p130 expression'
[patent_app_type] => new
[patent_app_number] => 10/161983
[patent_app_country] => US
[patent_app_date] => 2002-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29528
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20030225015.pdf
[firstpage_image] =>[orig_patent_app_number] => 10161983
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/161983 | Antisense modulation of Rb2/p130 expression | May 30, 2002 | Abandoned |
Array
(
[id] => 7212312
[patent_doc_number] => 20050054104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Targeted particles and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 10/478896
[patent_app_country] => US
[patent_app_date] => 2002-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17562
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054104.pdf
[firstpage_image] =>[orig_patent_app_number] => 10478896
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/478896 | Targeted particles and methods of using the same | May 27, 2002 | Issued |
| 10/019595 | Antisense modulation of mekk5 expression | May 21, 2002 | Abandoned |
| 10/018497 | Antisense modulation of g-alpha-i 3 expression | May 21, 2002 | Abandoned |
Array
(
[id] => 6821734
[patent_doc_number] => 20030219895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Antisense modulation of CDC-like kinase 1 expression'
[patent_app_type] => new
[patent_app_number] => 10/154708
[patent_app_country] => US
[patent_app_date] => 2002-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30428
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20030219895.pdf
[firstpage_image] =>[orig_patent_app_number] => 10154708
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/154708 | Antisense modulation of CDC-like kinase 1 expression | May 21, 2002 | Abandoned |
| 10/130080 | Antisense modulation of nck -2 expression | May 9, 2002 | Abandoned |
Array
(
[id] => 6639213
[patent_doc_number] => 20030212017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Antisense modulation of farnesyl transferase beta subunit expression'
[patent_app_type] => new
[patent_app_number] => 10/144488
[patent_app_country] => US
[patent_app_date] => 2002-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28822
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20030212017.pdf
[firstpage_image] =>[orig_patent_app_number] => 10144488
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/144488 | Antisense modulation of farnesyl transferase beta subunit expression | May 9, 2002 | Abandoned |
| 10/019470 | Antisense modulation of liver glycogen phosphorylase expression | May 8, 2002 | Abandoned |
Array
(
[id] => 8675675
[patent_doc_number] => 08383788
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-26
[patent_title] => 'C-Fos induced growth factor (FIGF) and DNA encoding same'
[patent_app_type] => utility
[patent_app_number] => 10/139876
[patent_app_country] => US
[patent_app_date] => 2002-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 36
[patent_no_of_words] => 9385
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10139876
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/139876 | C-Fos induced growth factor (FIGF) and DNA encoding same | May 6, 2002 | Issued |
Array
(
[id] => 6809525
[patent_doc_number] => 20030199464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Regeneration of endogenous myocardial tissue by induction of neovascularization'
[patent_app_type] => new
[patent_app_number] => 10/128738
[patent_app_country] => US
[patent_app_date] => 2002-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 17545
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20030199464.pdf
[firstpage_image] =>[orig_patent_app_number] => 10128738
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/128738 | Regeneration of endogenous myocardial tissue by induction of neovascularization | Apr 22, 2002 | Abandoned |
Array
(
[id] => 736987
[patent_doc_number] => 07033829
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-25
[patent_title] => 'Method to inhibit cell growth using oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 10/122633
[patent_app_country] => US
[patent_app_date] => 2002-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 82
[patent_no_of_words] => 28177
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/033/07033829.pdf
[firstpage_image] =>[orig_patent_app_number] => 10122633
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/122633 | Method to inhibit cell growth using oligonucleotides | Apr 11, 2002 | Issued |
| 09/913800 | Antisense modulation of akt -2 expression | Feb 28, 2002 | Abandoned |
